NewLink Genetics Corporation | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (33)

Latest Posts

About This Stock More About This Stock
Morning Call For Wednesday, October 4
Article By: Jim Van Meerten
Wednesday, October 4, 2017 10:17 AM EDT
Dec E-mini S&Ps (ESZ17 -0.02%) this morning are down -0.09% and European stocks are down -0.56% as weakness in crude oil drags energy stocks lower.
In this article: KHC, LEN, WGO, JACK, TSLA, GBT, CTMX, NLNK, ODP, I, RIGL
Read
Merck Receives Breakthrough Therapy Designation, PRIME Status For V920
Article By: The Fly
Monday, July 25, 2016 10:08 AM EDT
V920 was initially engineered by scientists from the Public Health Agency of Canada's National Microbiology Laboratory and subsequently licensed to a subsidiary of NewLink Genetics Corporation.
In this article: MRK Also: NLNK
Read
CytomX Long Term Returns Uncertain
Article By: Don Dion
Tuesday, October 6, 2015 12:00 PM EDT
CTMX is the largest biotech this week to debut; investors could buy in at higher rates than slightly lower profile firms. CTMX has impressive partnerships with big pharma and is backed by Third Rock Ventures, Fidelity and Pfizer.
In this article: AZN, GSK, MRK, NVS, PFE, ROG, SNY, VRX, IDRA, IMGN, NLNK, SGEN, CELG, JUNO, KITE, BLUE, BLCM, ACRS
Read
Free Cash Yield Vs. Earnings Yield To Rank Magic Formula Stocks
Article By: Steve Alexander
Thursday, June 11, 2015 7:12 AM EDT
Most value investors will tell you that free cash flow is the purest measure of a company's success. The purpose of a business is to use assets to generate cash.
In this article: DEPO, KING, NLNK, NSR, TSRA, PDLI, PINC, LTRPA, TNH, AAPL, GILD, SCAI, AMSG, MSFT
Read

Latest Tweets for $NLNK

No tweets yet!

PARTNER HEADLINES